14,15-epoxy-5,8,11-eicosatrienoic acid has been researched along with Peripheral Vascular Diseases in 1 studies
14,15-epoxy-5,8,11-eicosatrienoic acid: RN given refers to cpd without isomeric designation
Peripheral Vascular Diseases: Pathological processes involving any one of the BLOOD VESSELS in the vasculature outside the HEART.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chadderdon, SM | 1 |
| Belcik, JT | 1 |
| Smith, E | 1 |
| Pranger, L | 1 |
| Kievit, P | 1 |
| Grove, KL | 1 |
| Lindner, JR | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Physical Activity and Obesity: The Role of Nitric Oxide and Eicosanoids in Regulating Capillary Perfusion and Vascular Insulin Resistance[NCT02060240] | 30 participants (Actual) | Interventional | 2014-02-28 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 other study available for 14,15-epoxy-5,8,11-eicosatrienoic acid and Peripheral Vascular Diseases
| Article | Year |
|---|---|
Activity restriction, impaired capillary function, and the development of insulin resistance in lean primates.
Topics: 8,11,14-Eicosatrienoic Acid; Animals; Brachial Artery; Capillaries; Contrast Media; Glucose Toleranc | 2012 |